Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray

Neoplasma

Volumn 55, Issue 5, 2008, Pages 447-454

  Herak Bosnar, M ^a   Bago, R ^a   Konjevoda, P ^a   Pavelic J ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

DNA microarray; nm23 H2; Oral squamous cell carcinoma

Indexed keywords

ALPHA INTEGRIN; ANKYRIN; CALGRANULIN A; CALGRANULIN B; CASPASE 2; CLATHRIN; CYCLIN DEPENDENT KINASE 1; CYTOKERATIN 1; CYTOKERATIN 10; CYTOKERATIN 13; CYTOKERATIN 17; CYTOKERATIN 6; DYNAMIN; EPOXIDE HYDROLASE; HEAT SHOCK PROTEIN 70; INVOLUCRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METALLOPROTEINASE; PHOSPHOLIPASE C BETA3; PROTEASOME; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PSORIASIN; TALIN; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; UNINDEXED DRUG; WNT PROTEIN; ZINC FINGER PROTEIN; ZYXIN; NUCLEOSIDE DIPHOSPHATE KINASE NM23;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL STRUCTURE; DNA DAMAGE; DNA MICROARRAY; EPITHELIUM CELL; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MICROARRAY ANALYSIS; NM23 H2 GENE; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; DISEASE COURSE; GENETIC TRANSFECTION; GENETICS; MOUTH TUMOR; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MOUTH NEOPLASMS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 53449092256     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. DE LA ROSA A, WILLIAMS RL, STEEG PS. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. BioEssays 1994; 17: 53-62
2. GILLES A, PRESECAN E, VONICA A et al. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991; 266: 8784-8789
3. LACOMBE M-L, MILON L, MUNIER A et al. The human Nm23/nucleoside diphosphate kinase. J Bioenerg Biomembr 2000; 32:247-258
4. STEEG PS, BEVILACQUA G, KOPPER L et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988; 80: 200-204
5. HARTSOUGH MT, STEEG PS. Nm23/nucleoside diphosphate kinase in human cancers. J Bioenerg Biomembr 2000; 32: 301-308 (Pubitemid 30727495)
6. CALIGO MA, CIPOLLINI G, BERTI A et al. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. Int J Cancer. 1997; 74:102-111
7. CALIGO MA, CIPOLLINI G, FIORE L et al. Nm23 gene expression correlates with cell growth rate and S-phase. Int J Cancer 1995; 60: 837-842
8. LAKSO M, STEEG PS, WESTPHAL H. Embryonic expression of Nm23 during mouse organogenesis. Cell Growth Diff 1992; 3: 873-879
9. ROSENGARD AM, KRUTZSCH HC, SHEARN A et al. Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 1989; 342: 177-180
10. GERVASI F, D'AGNANO I, VOSSIO S et al. nm23 influences proliferation and differentiation of PC12 cell in response to nerve growth factor. Cell Growth Diff 1996; 7: 1689-1695 (Pubitemid 26415165)
11. KRISHNAN KS, RIKHY R, RAO S et al. Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron 2001; 30: 197-210
12. ARNAUD-DABERNAT S, MASSE K, SMANI M et al. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinase protect the cells from oxidative stress-induced death. Exp Cell Res 2004; 301: 293-304
13. JANG A, HILL RP. An examination of the effects of hypoxia, acidosis and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 1997; 15: 469-483 (Pubitemid 27323897)
14. PALACIOS F, SCHWEITZER JK, BOSHANS RL et al. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nature Cell Biol 2002; 4: 929-936
15. ROCHDI MD, LAROCHE G, DUPRE E et al. Nm23-H2 interacts with a G protein-coupled receptor to regulate its endocytosis trough an Rac-dependent mechanism. J Biol Chem 2004; 279: 18981-18989
16. JEFFREY A, NICKERSON JA, WELLS WW. The microtubule-associated nucleoside diphosphate kinase. J Biol Chem 1984; 259: 11297-11304
17. MA D, XING Z, PEDIGO NG et al. NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem 2002; 277: 1560-1567
18. OTERO AD. NM23/Nucleoside diphosphate kinase and signal transduction. J Bioenerg Biomembr 2000; 32: 269-275 (Pubitemid 30727491)
19. POSTEL EH, BERBERICH SJ, FLINT SJ et al. Human cmyc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 1993; 261: 478-480 (Pubitemid 23276558)
20. POSTEL EH, FERRONE CA. Nucleoside diphosphate kinase enzyme activity of Nm23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. J Biol Chem 1994; 269: 8627-8630
21. FOURNIER NH, DUPE-MANET S, BOUVARD D et al. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J Biol Chem 2002; 277: 20895-208902
22. WANG YF, CHOW KC, CHANG SY et al. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 2004; 90: 2186-2193 (Pubitemid 38869728)
23. LO MUZIO L, MIGNOGNA MD, PANNONE G et al. The NM23 gene and its expression in oral squamous cell carcinoma. Oncol Rep 1999; 6: 747-751
24. KHAN MH, YASUDA M, HIGASHINO F et al. Nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 2001; 158: 1785-1791
25. OTSUKI K, ALCALDE RE, MATSUMURA T. Immunohistochemical analysis of nucleoside diphosphate kinases in oral squamous cell carcinomas. Oncology 1997; 54: 63-68 (Pubitemid 26413321)
26. HERAK BOSNAR M, BAGO R, GALL-TROŠELJ K et al. Downstream targets of Nm23-H1: gene expression profiling of CAL 27 cells using DNA microarray. Mol Carcinogen 2006; 45: 627-633 (Pubitemid 44205102)
27. MOLL UM, SLADE N. p63 and p73: roles in developement and tumor formation. Mol Cancer Res 2004; 2: 371-386
28. WHYTE DA, BROTON CE, SHILLITOE EJ. The unexpected survival of cells in oral cancer: what is the role of p53? J Oral Pathol Med 2002; 31: 125-133
29. DOTTO GP. P21WAF/Cip1: more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43-56
30. MIYAZAKI H, FUKUDA M, ISHIJAMA Y et al. Overexpression of nm23-H2/NDP kinase in human oral syuamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in metastatic site and growth factor-independent proliferative activity in culture. Clin Cancer Res 1999; 5: 4301-4307
31. CIPOLLINI G, BERTI A, FIORE L et al. Down-Regulation of the nm23-H1 gene inhibits cell proliferation. Int J Cancer 1997; 73: 297-302 (Pubitemid 27448834)
32. KANG Y, LEE DC, HAN J ET AL. NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Biochem Biophys Res Commun 2007; 359: 76-82
33. FAN Z, BERESFORD PJ, OH DY, ZHANG D et al. Tumor suppressor NM23-H1 is a Granzyme A-activat4ed DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell; 2003: 112: 659-672
34. TURPEENNIEMI-HUJANEN T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005; 87: 287-297
35. JOHANSSON N, ARIOLA K, GRENMAN R et al. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinoma of the head and neck. Am J Pathol 1997; 151: 499-1408
36. ROSENTHAL EL, MATRISIAN LM. Matrix metalloproteinases in head and neck cancer. Head Neck 2006; 28: 639-648 (Pubitemid 44025114)
37. ENGERS R, GABBERT HE. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol 2000; 126: 682-692
38. BRAKEBUSCH C, FASSLER R. β1 integrin function in vivo. Adhesion, migration and more. Cancer Metastasis Rev 2005; 24: 403-411
39. NARAYANAN R, RAMASWAMI M. Regulation of dynamin by nucleoside diphosphate kinase. J Bioenerg Biomembr 2003; 35: 49-55 (Pubitemid 36667580)
40. PRESLAND RB, DALE BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 2000; 11:383-408
41. URAGUCHI M, MORIKAWA M, SHIRAKAWA M et al. Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 2004; 83: 327-332 (Pubitemid 41713770)
42. LO MUZIO L. A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev Oral Biol Med 2001; 12: 152-165
43. LEUNG S-M, HIGHTOWER LE. A 16 kDa protein functions as a new regulatory protein for HSC70 molecular chaperone and is identified as a member of the Nm23/nucleoside diphosphate kinase family. J Biol Chem 1997; 272: 2607-2614
44. ZHAO H, JHANVAR-UNIYAL M, DATTA PK et al. Expression profile of genes associated with antimetastatic gene: NM23-mediated metastasis inhibition in breast carcinoma cells. Int J Cancer 2004; 109: 65-70